211 related articles for article (PubMed ID: 8908943)
1. IIb/IIIa platelet inhibitors in the management of coronary artery disease.
Talley JD
J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943
[No Abstract] [Full Text] [Related]
2. Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?
Lincoff AM; Topol EJ
Eur Heart J; 2000 Jun; 21(11):863-7. PubMed ID: 10806004
[No Abstract] [Full Text] [Related]
3. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
Goldschmidt-Clermont PJ
J Invasive Cardiol; 2002 Dec; 14 Suppl E():1E. PubMed ID: 12668856
[No Abstract] [Full Text] [Related]
4. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
[TBL] [Abstract][Full Text] [Related]
5. [Glycoprotein IIb/IIIa antagonists].
Hennemann A
Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
[No Abstract] [Full Text] [Related]
6. Newer therapeutic concept in antiplatelet aggregation inhibition--GPIIb-IIIa receptor antagonists.
Malhotra S; Mishra NK; Sinha RS; Gupta B
J Assoc Physicians India; 2000 Mar; 48(3):329-34. PubMed ID: 11229122
[TBL] [Abstract][Full Text] [Related]
7. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
Popma JJ; Satler LF
J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
Mukherjee D; Roffi M
J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
[No Abstract] [Full Text] [Related]
9. Care of the patient receiving ReoPro following angioplasty.
Brezina K; Murphy M; Stonner T
J Invasive Cardiol; 1994; 6 Suppl A():38A-42A; discussion 54A-56A. PubMed ID: 10155094
[No Abstract] [Full Text] [Related]
10. [Theombolysis with GP IIb/IIIa-receptor blockader. Platelt aggregation inhibition: clear indications, new strategies].
Internist (Berl); 1998 Dec; 39(12 Suppl Plattchena):1-4. PubMed ID: 10101692
[No Abstract] [Full Text] [Related]
11. Unsticking platelets: the role of glycoprotein IIb/IIIa receptor blockade.
Armstrong PW
CMAJ; 1999 Nov; 161(11):1423-4. PubMed ID: 10906900
[No Abstract] [Full Text] [Related]
12. Post-procedural patient management: prevention and management of bleeding complications.
Aguirre F
J Invasive Cardiol; 1994; 6 Suppl A():34A-37A; discussion 54A-56A. PubMed ID: 10155093
[No Abstract] [Full Text] [Related]
13. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
Gambassi G; Landolfi R; Bernabei R
N Engl J Med; 1997 Oct; 337(17):1243-4. PubMed ID: 9340528
[No Abstract] [Full Text] [Related]
14. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
Khan SS; Forrester J
N Engl J Med; 1997 Oct; 337(17):1243; author reply 1244-5. PubMed ID: 9340527
[No Abstract] [Full Text] [Related]
15. Glycoprotein IIb/IIIa inhibitors: current indications and future prospects.
Reginelli JP; Topol EJ
Am J Med; 2000 Aug; 109(3):252-4. PubMed ID: 10974193
[No Abstract] [Full Text] [Related]
16. Ischemic coronary syndromes and SVG Interventions--do 2b/3a inhibitors miss the target?
Topaz O
Catheter Cardiovasc Interv; 2007 Apr; 69(5):630-1. PubMed ID: 17377986
[No Abstract] [Full Text] [Related]
17. The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide.
Moliterno DJ; Ziada KM
J Am Coll Cardiol; 2008 Feb; 51(5):536-7. PubMed ID: 18237681
[No Abstract] [Full Text] [Related]
18. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.
Gambhir DS; Mukhopadhyay S
Indian Heart J; 2000; 52(5):524-32. PubMed ID: 11256774
[No Abstract] [Full Text] [Related]
19. Glycoprotein IIb-IIIa antagonists in percutaneous coronary interventions and acute coronary syndromes.
Ramanathan A; Kleiman NS
Indian Heart J; 1998 Oct; 50 Suppl 1():45-56. PubMed ID: 9824907
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of the platelet glycoprotein IIb/IIIa inhibitor abciximab in Chinese patients undergoing high-risk angioplasty.
Chen YH; Chen JW; Wu TC; Ding PY; Wang SP; Chang MS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):8-15. PubMed ID: 10645045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
